The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
- collapse A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
- collapse A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
- collapse QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
- collapse Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD8931
- collapse Assessment of the Safety, Tolerability and Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules.
- collapse Non-interventional observational study to evaluate change of PSA levels in patients with advanced prostate cancer treated with bicalutamide in combination with medical or surgical castration
- collapse Prevalence of osteoporosis in Korean prostate cancer patients who is reciving LHRH agonist and/or anti-androgen agent
- collapse A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
- collapse Protection of Ovarian Function with Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study
